UMeWorld Limited Announces Groundbreaking Study Published in the Journal of Lipid Research, Highlighting the Benefits of Low Triglyceride DAGola Cooking Oil for Athletes
MWN-AI** Summary
UMeWorld Limited (OTC: UMEWF) has made headlines with the publication of a pivotal study in the *Journal of Lipid Research* titled “Lipidomics and Metabolomics Investigation into the Effect of DAG Dietary Intervention on Hyperuricemia in Athletes.” This research highlights the advantages of DAGola, the company’s diacylglycerol (DAG) cooking oil, particularly for athletes who might struggle with elevated uric acid levels despite their physical activity.
The study is ground-breaking in that it uniquely investigates the impact of DAG-enriched diets on athletes. It found that incorporating DAGola oil led to a significant reduction in serum uric acid levels, which is crucial for preventing conditions like gout, diabetes, and cardiovascular diseases. Notably, the research comprehensively evaluated over 1,000 types of fats and metabolites in athletes, revealing that those who integrated DAGola into their diets saw improved blood lipid profiles and metabolic health.
Key outcome measures demonstrated that the DAG diet was associated with decreased triglyceride levels, reduced oxidative stress, and enhanced metabolic processing of waste products that can hinder athletic performance. The sustained health benefits noted during the intervention indicate the potential for long-term positive impacts on health from regular use of DAGola oil.
Michael Lee, CEO of UMeWorld, expressed enthusiasm about the study, emphasizing its scientific backing for DAGola oil as a healthful cooking option. He highlighted the potential of their product to foster better metabolic health and athletic performance, reinforcing UMeWorld’s commitment to innovation in both functional cooking oils and sustainable biofuels. The findings bolster DAGola’s reputation as a forward-thinking solution in the cooking oil market.
MWN-AI** Analysis
UMeWorld Limited (OTC: UMEWF) has recently made headlines with the publication of a significant clinical study in the *Journal of Lipid Research* regarding its DAGola cooking oil. This study not only underscores the health benefits of diacylglycerol (DAG) for athletes but also positions UMeWorld as an innovator in the health-focused food product sector. Given the findings regarding lower triglyceride and uric acid levels, coupled with enhanced athletic performance, investors should consider the implications for both the stock's potential and market positioning.
With increasing consumer awareness around health and nutrition, UMeWorld’s DAGola cooking oil could capitalize on a growing market segment seeking functional foods. The study highlights DAGola’s unique selling proposition—a healthier alternative to traditional cooking oils—potentially appealing to both health-conscious consumers and competitive athletes.
Investors should monitor several key indicators. First, watch for sales growth in the DAGola product line, especially any partnership announcements with athletic organizations or endorsements from sports professionals. Increased visibility in targeted marketing campaigns can lead to greater market penetration.
Secondly, as UMeWorld continues to build its scientific backing through research publications, it could gain credibility, further enhancing brand strength. The ongoing consumer trend towards scientifically validated health products may bolster demand and enhance sales volume.
However, investors should approach with caution due to inherent market volatility, especially in the health and wellness sector. Regulatory changes, competitor advancements, and changing consumer preferences can affect performance.
Overall, UMeWorld’s recent study positions the company for potential growth within a dynamically evolving market. For investors, understanding the interplay between research validation and market strategies will be crucial for assessing the stock’s potential trajectory in the coming quarters.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
MIAMI, Feb. 18, 2025 (GLOBE NEWSWIRE) -- UMeWorld Limited (OTC: UMEWF) is pleased to announce the publication of a groundbreaking clinical study in the Journal of Lipid Research , titled “Lipidomics and Metabolomics Investigation into the Effect of DAG Dietary Intervention on Hyperuricemia in Athletes.” The study demonstrates the significant health benefits of DAGola-branded diacylglycerol (DAG) cooking oil, revealing its potential role in managing hyperuricemia (HUA) and reducing the risk of related health problems such as gout, diabetes, and cardiovascular disease.
This pioneering research is the first to explore the effects of a DAG-enriched diet specifically for athletes, who, despite being physically active, can still be prone to elevated uric acid levels, a condition that increases the risk of metabolic diseases. The study found that incorporating DAGola cooking oil into the athletes' diets led to a notable reduction in uric acid levels, suggesting its potential to not only improve performance but also support long-term health.
Key Findings from the Study:
- Comprehensive Lipidomics and Metabolomics Analysis: Researchers analyzed over 1,000 types of fats and metabolites in athletes' blood to determine the effects of the DAG diet. Results showed improved blood lipid profiles and metabolic health markers in those consuming DAGola oil.
- Significant Reduction in Uric Acid Levels: Athletes who responded positively to the DAG diet experienced a notable drop in serum uric acid levels, a key factor in preventing gout and other metabolic disorders. Non-responders showed no such changes, highlighting the personalized health benefits of DAGola oil.
- Healthier Blood Profiles: The DAG diet contributed to lower triglycerides, healthier fat levels in the blood, and reduced oxidative stress caused by free radicals, which are linked to muscle recovery and inflammation.
- Improved Waste Processing: Athletes on the DAG diet demonstrated enhanced metabolic processing of waste products like ammonia, which can otherwise lead to fatigue and decreased performance.
- Sustained Benefits Over Time: Reductions in serum triglycerides and uric acid levels remained significant throughout the intervention period, indicating that continued use of DAGola cooking oil may help maintain these health benefits.
Published in the highly respected Journal of Lipid Research , this study brings scientific rigor to the health claims surrounding DAGola cooking oil. Enriched with diacylglycerol (DAG), a lipid compound that metabolizes faster than traditional triglycerides, DAGola oil provides a healthier cooking option for athletes, offering quick energy without the metabolic stress associated with higher triglyceride oils.
DAG-based oil has been well-researched since 2000, with numerous clinical trials demonstrating its benefits in improving fat metabolism, reducing triglyceride levels, and supporting cardiovascular health. The findings from this latest study reinforce the existing body of research, further validating DAGola’s role in promoting metabolic health and athletic performance.
By reducing uric acid levels and improving blood fat profiles, DAGola oil could help prevent common conditions like gout, heart disease, and kidney problems - issues that could otherwise compromise performance and long-term health.
Michael Lee, CEO of UMeWorld Limited, said: "We are incredibly excited by the findings published in the Journal of Lipid Research, which provide valuable scientific validation of DAGola cooking oil’s health benefits for athletes. This research highlights the potential for DAGola oil to improve key health markers like uric acid and triglycerides, ultimately helping athletes achieve better performance and long-term wellness. Our team is proud to lead the way in producing products that support healthier lifestyles, and we’re thrilled to see the positive impact DAGola oil is having on athletes' health. As the study suggests, small dietary changes - like switching to DAGola cooking oil - can have a big impact on health. UMeWorld is excited to continue pioneering research that helps individuals live healthier, more active lives.”
About UMeWorld
At UMeWorld, we merge innovation with science to revolutionize the cooking oil industry. DAGola™ oil is a science-backed alternative with up to 80% less triglycerides, helping combat metabolic syndrome, which affects 47 million Americans. Our advanced processes also convert various vegetable oils, including palm and used cooking oil, into high-value products like biodiesel. Our goal is to become a leader in next-generation functional cooking oils and eco-friendly biofuels, driving innovation and sustainability in both industries.
About DAGola Inc.
DAGola Inc. is the U.S. branch of UMeWorld Limited. It focuses on selling innovative food products in North America. To learn more about DAGola Inc., visit www.dagolaoil.com and amazon.com/dagola
Forward-Looking Statements
This press release may contain forward-looking statements, about UMeWorld's expectations, beliefs or intentions regarding, among other things, its product development efforts, business, financial condition, results of operations, strategies or prospects. In addition, from time to time, UMeWorld or its representatives have made or may make forward-looking statements, orally or in writing. Forward-looking statements can be identified by the use of forward-looking words such as "believe," "expect," "intend," "plan," "may," "should" or "anticipate" or their negatives or other variations of these words or other comparable words or by the fact that these statements do not relate strictly to historical or current matters. These forward-looking statements may be included in, but are not limited to, various filings made by UMeWorld with the U.S. Securities and Exchange Commission, press releases or oral statements made by or with the approval of one of UMeWorld's authorized executive officers. Forward-looking statements relate to anticipated or expected events, activities, trends or results as of the date they are made. Because forward looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties that could cause UMeWorld's actual results to differ materially from any future results expressed or implied by the forward-looking statements. Many factors could cause UMeWorld's actual activities or results to differ materially from the activities and results anticipated in such forward-looking statements, including, but not limited to, the factors summarized in UMeWorld's filings with the SEC. In addition, UMeWorld operates in an industry sector where securities values are highly volatile and may be influenced by economic and other factors beyond its control. UMeWorld does not undertake any obligation to publicly update these forward-looking statements, whether as a result of new information, future events or otherwise. Please see the risk factors associated with an investment in our securities which are included in our Annual Report on Form 20-F and other periodic and current reports filed with the Securities and Exchange Commission.
Contact:Michael LeeUMeWorld LimitedEmail: info@umeworld.com
FAQ**
How does the recent study published in the Journal of Lipid Research validate UMeWorld Ltd UMEWF's claims regarding the health benefits of DAGola cooking oil for athletes?
What specific measures is UMeWorld Ltd UMEWF taking to capitalize on the positive findings of the DAG dietary intervention for managing hyperuricemia in athletes?
Can you explain how UMeWorld Ltd UMEWF plans to differentiate DAGola cooking oil from other cooking oils in the saturated market based on the study's findings?
What potential market opportunities does UMeWorld Ltd UMEWF foresee for DAGola oil, given its documented benefits in reducing serum uric acid levels and improving metabolic health?
**MWN-AI FAQ is based on asking OpenAI questions about UMeWorld Ltd (OTC: UMEWF).
NASDAQ: UMEWF
UMEWF Trading
41900.0% G/L:
$0.42 Last:
1,000 Volume:
$0.42 Open:
